

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | intestinal cholesterol absorption (GO:0030299) | 9.78273232 |
| 2 | angiotensin maturation (GO:0002003) | 8.07524976 |
| 3 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 7.40125387 |
| 4 | regulation of guanylate cyclase activity (GO:0031282) | 7.36658332 |
| 5 | epoxygenase P450 pathway (GO:0019373) | 6.27702038 |
| 6 | fat-soluble vitamin biosynthetic process (GO:0042362) | 5.83906984 |
| 7 | flavonoid metabolic process (GO:0009812) | 5.78280441 |
| 8 | intestinal epithelial cell development (GO:0060576) | 5.71893877 |
| 9 | regulation of bile acid biosynthetic process (GO:0070857) | 5.71729195 |
| 10 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 5.67587613 |
| 11 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 5.67587613 |
| 12 | digestive system process (GO:0022600) | 5.67207409 |
| 13 | positive regulation of guanylate cyclase activity (GO:0031284) | 5.54602176 |
| 14 | actin filament depolymerization (GO:0030042) | 5.45404607 |
| 15 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.39714208 |
| 16 | vitamin A metabolic process (GO:0006776) | 5.38831667 |
| 17 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 5.35303217 |
| 18 | maintenance of gastrointestinal epithelium (GO:0030277) | 5.22892097 |
| 19 | regulation of cellular extravasation (GO:0002691) | 4.98158741 |
| 20 | uronic acid metabolic process (GO:0006063) | 4.89719763 |
| 21 | glucuronate metabolic process (GO:0019585) | 4.89719763 |
| 22 | drug catabolic process (GO:0042737) | 4.83371193 |
| 23 | fructose metabolic process (GO:0006000) | 4.78213106 |
| 24 | regulation of systemic arterial blood pressure (GO:0003073) | 4.75482033 |
| 25 | bile acid and bile salt transport (GO:0015721) | 4.66346274 |
| 26 | response to hepatocyte growth factor (GO:0035728) | 4.54066736 |
| 27 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 4.54066736 |
| 28 | peptide hormone processing (GO:0016486) | 4.50905395 |
| 29 | renal system process involved in regulation of blood volume (GO:0001977) | 4.49527180 |
| 30 | regulation of cGMP biosynthetic process (GO:0030826) | 4.46749662 |
| 31 | phospholipid efflux (GO:0033700) | 4.38867775 |
| 32 | digestion (GO:0007586) | 4.27882385 |
| 33 | hormone catabolic process (GO:0042447) | 4.27308713 |
| 34 | alkaloid metabolic process (GO:0009820) | 4.24773580 |
| 35 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.24002515 |
| 36 | sulfate transmembrane transport (GO:1902358) | 4.19863255 |
| 37 | regulation of vitamin metabolic process (GO:0030656) | 4.17447135 |
| 38 | glucose 6-phosphate metabolic process (GO:0051156) | 4.17219063 |
| 39 | plasma lipoprotein particle assembly (GO:0034377) | 4.11976571 |
| 40 | lipoprotein metabolic process (GO:0042157) | 4.11698279 |
| 41 | regulation of cholesterol esterification (GO:0010872) | 4.01862071 |
| 42 | epithelial structure maintenance (GO:0010669) | 3.99718084 |
| 43 | regulation of triglyceride catabolic process (GO:0010896) | 3.95002263 |
| 44 | glycolipid catabolic process (GO:0019377) | 3.91046039 |
| 45 | regulation of cholesterol homeostasis (GO:2000188) | 3.90628647 |
| 46 | O-glycan processing (GO:0016266) | 3.89186819 |
| 47 | glycosphingolipid catabolic process (GO:0046479) | 3.87649802 |
| 48 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.87433649 |
| 49 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.87433649 |
| 50 | protein-lipid complex assembly (GO:0065005) | 3.86928985 |
| 51 | bicarbonate transport (GO:0015701) | 3.85453651 |
| 52 | adhesion of symbiont to host cell (GO:0044650) | 3.84852817 |
| 53 | virion attachment to host cell (GO:0019062) | 3.84852817 |
| 54 | sulfation (GO:0051923) | 3.83709540 |
| 55 | endocrine pancreas development (GO:0031018) | 3.80631574 |
| 56 | nitrogen cycle metabolic process (GO:0071941) | 3.80221882 |
| 57 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.76622080 |
| 58 | transcytosis (GO:0045056) | 3.73318792 |
| 59 | positive regulation of pseudopodium assembly (GO:0031274) | 3.70788205 |
| 60 | positive regulation of respiratory burst (GO:0060267) | 3.65979545 |
| 61 | vitamin transmembrane transport (GO:0035461) | 3.65207584 |
| 62 | regulation of cGMP metabolic process (GO:0030823) | 3.64201179 |
| 63 | modified amino acid transport (GO:0072337) | 3.63619719 |
| 64 | antibacterial humoral response (GO:0019731) | 3.62768463 |
| 65 | cholesterol efflux (GO:0033344) | 3.61312281 |
| 66 | cGMP-mediated signaling (GO:0019934) | 3.60555006 |
| 67 | sperm capacitation (GO:0048240) | 3.57318939 |
| 68 | cholesterol homeostasis (GO:0042632) | 3.57102759 |
| 69 | antimicrobial humoral response (GO:0019730) | 3.55597438 |
| 70 | sterol homeostasis (GO:0055092) | 3.55354025 |
| 71 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.54009531 |
| 72 | nucleotide-sugar metabolic process (GO:0009225) | 3.53293082 |
| 73 | transepithelial transport (GO:0070633) | 3.52381941 |
| 74 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.52223995 |
| 75 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.51439790 |
| 76 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.47230018 |
| 77 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.46625343 |
| 78 | COPII vesicle coating (GO:0048208) | 3.46538569 |
| 79 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 3.43197241 |
| 80 | NADH metabolic process (GO:0006734) | 3.41816454 |
| 81 | sulfate transport (GO:0008272) | 3.38271507 |
| 82 | sulfur compound transport (GO:0072348) | 3.37308703 |
| 83 | cholesterol transport (GO:0030301) | 3.36318449 |
| 84 | sterol transport (GO:0015918) | 3.36318449 |
| 85 | negative regulation of cholesterol transport (GO:0032375) | 3.35640866 |
| 86 | negative regulation of sterol transport (GO:0032372) | 3.35640866 |
| 87 | glandular epithelial cell differentiation (GO:0002067) | 3.34972935 |
| 88 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.33147434 |
| 89 | regulation of pseudopodium assembly (GO:0031272) | 3.32535183 |
| 90 | cellular response to nitric oxide (GO:0071732) | 3.32336573 |
| 91 | membrane repolarization during action potential (GO:0086011) | 3.30830417 |
| 92 | lipoprotein transport (GO:0042953) | 3.30221703 |
| 93 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.29693172 |
| 94 | ethanol oxidation (GO:0006069) | 3.29369412 |
| 95 | peptide catabolic process (GO:0043171) | 3.27379239 |
| 96 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.26883079 |
| 97 | vitamin transport (GO:0051180) | 3.25379571 |
| 98 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.24256597 |
| 99 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 3.22336404 |
| 100 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.21045714 |
| 101 | arginine metabolic process (GO:0006525) | 3.20943742 |
| 102 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.20813589 |
| 103 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.20621257 |
| 104 | drinking behavior (GO:0042756) | 3.19918151 |
| 105 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.19623200 |
| 106 | positive regulation of cGMP biosynthetic process (GO:0030828) | 3.19387085 |
| 107 | glycosylceramide metabolic process (GO:0006677) | 3.18097112 |
| 108 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.17896538 |
| 109 | bile acid metabolic process (GO:0008206) | 3.17853685 |
| 110 | sphingomyelin metabolic process (GO:0006684) | 3.16129304 |
| 111 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.15572490 |
| 112 | positive regulation of lipid catabolic process (GO:0050996) | 3.14903640 |
| 113 | auditory receptor cell differentiation (GO:0042491) | 3.13954735 |
| 114 | glycerol metabolic process (GO:0006071) | 3.12172697 |
| 115 | disruption of cells of other organism (GO:0044364) | 3.12161690 |
| 116 | killing of cells of other organism (GO:0031640) | 3.12161690 |
| 117 | fat-soluble vitamin metabolic process (GO:0006775) | 3.12076923 |
| 118 | ceramide catabolic process (GO:0046514) | 3.10648501 |
| 119 | glomerular filtration (GO:0003094) | 3.09606667 |
| 120 | COPI coating of Golgi vesicle (GO:0048205) | 3.09151257 |
| 121 | Golgi transport vesicle coating (GO:0048200) | 3.09151257 |
| 122 | columnar/cuboidal epithelial cell development (GO:0002066) | 3.07637246 |
| 123 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.05604886 |
| 124 | regulation of actin nucleation (GO:0051125) | 3.05485844 |
| 125 | cellular response to reactive nitrogen species (GO:1902170) | 3.04807328 |
| 126 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 3.03336605 |
| 127 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 3.03336605 |
| 128 | endocrine process (GO:0050886) | 3.03336605 |
| 129 | diacylglycerol metabolic process (GO:0046339) | 3.03248067 |
| 130 | oligosaccharide catabolic process (GO:0009313) | 3.02067638 |
| 131 | oligosaccharide biosynthetic process (GO:0009312) | 3.01677003 |
| 132 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.01481235 |
| 133 | sexual reproduction (GO:0019953) | 3.00909624 |
| 134 | adhesion of symbiont to host (GO:0044406) | 2.99381407 |
| 135 | drug transmembrane transport (GO:0006855) | 2.98760084 |
| 136 | thyroid hormone metabolic process (GO:0042403) | 2.96571213 |
| 137 | reverse cholesterol transport (GO:0043691) | 2.96059667 |
| 138 | urea metabolic process (GO:0019627) | 2.95909136 |
| 139 | urea cycle (GO:0000050) | 2.95909136 |
| 140 | exogenous drug catabolic process (GO:0042738) | 2.89500497 |
| 141 | regulation of digestive system process (GO:0044058) | 2.89426792 |
| 142 | cell communication involved in cardiac conduction (GO:0086065) | 2.89343390 |
| 143 | drug transport (GO:0015893) | 2.87587534 |
| 144 | homocysteine metabolic process (GO:0050667) | 2.84924401 |
| 145 | ethanol metabolic process (GO:0006067) | 2.84433637 |
| 146 | drug metabolic process (GO:0017144) | 2.84172598 |
| 147 | cellular glucuronidation (GO:0052695) | 2.82992552 |
| 148 | intestinal absorption (GO:0050892) | 11.4249420 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 7.32625241 |
| 2 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 5.88452895 |
| 3 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 4.41669625 |
| 4 | GATA4_25053715_ChIP-Seq_YYC3_Human | 3.37145177 |
| 5 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 3.26482773 |
| 6 | GATA6_25053715_ChIP-Seq_YYC3_Human | 3.13727935 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.00238989 |
| 8 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.99434853 |
| 9 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.90955755 |
| 10 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.90534768 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.71218069 |
| 12 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.65979623 |
| 13 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.64707995 |
| 14 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.56107102 |
| 15 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.08217785 |
| 16 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.95172066 |
| 17 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.92696063 |
| 18 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.88784844 |
| 19 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.85808760 |
| 20 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.84888960 |
| 21 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.78495364 |
| 22 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.77873039 |
| 23 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.76442514 |
| 24 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.74117217 |
| 25 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.74042283 |
| 26 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.71231683 |
| 27 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.63748379 |
| 28 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.62126517 |
| 29 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.62019531 |
| 30 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.61506937 |
| 31 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.60632018 |
| 32 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.56514651 |
| 33 | GATA1_22025678_ChIP-Seq_K562_Human | 1.56239440 |
| 34 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.53018820 |
| 35 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.53012090 |
| 36 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.51526015 |
| 37 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.47942095 |
| 38 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.46752704 |
| 39 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.43992541 |
| 40 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.43640918 |
| 41 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.41961305 |
| 42 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.41227818 |
| 43 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.37530566 |
| 44 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.36972139 |
| 45 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.34093921 |
| 46 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.33824244 |
| 47 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.27645699 |
| 48 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.25851741 |
| 49 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.25683759 |
| 50 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.24524171 |
| 51 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.21028083 |
| 52 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.20498190 |
| 53 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.19671445 |
| 54 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.19556620 |
| 55 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.19352894 |
| 56 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.19273895 |
| 57 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.18303493 |
| 58 | ATF3_27146783_Chip-Seq_COLON_Human | 1.17549211 |
| 59 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.17283646 |
| 60 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.17113211 |
| 61 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.15935067 |
| 62 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.13893980 |
| 63 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.13025540 |
| 64 | GATA2_19941826_ChIP-Seq_K562_Human | 1.09656889 |
| 65 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.07849008 |
| 66 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.07238285 |
| 67 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.06454508 |
| 68 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.06380181 |
| 69 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.04482705 |
| 70 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.03802980 |
| 71 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.03797537 |
| 72 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.03133423 |
| 73 | VDR_22108803_ChIP-Seq_LS180_Human | 1.02675011 |
| 74 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.02113595 |
| 75 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.01703542 |
| 76 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.01071426 |
| 77 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.00317679 |
| 78 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.00088668 |
| 79 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.99996092 |
| 80 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.99889475 |
| 81 | GATA1_19941826_ChIP-Seq_K562_Human | 0.99539503 |
| 82 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.98465006 |
| 83 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.98102817 |
| 84 | RXR_22108803_ChIP-Seq_LS180_Human | 0.97157004 |
| 85 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96576858 |
| 86 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.94351473 |
| 87 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.93669059 |
| 88 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.92501879 |
| 89 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.90716573 |
| 90 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.90201897 |
| 91 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.89777039 |
| 92 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.88833826 |
| 93 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.88259972 |
| 94 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.87863784 |
| 95 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.87814392 |
| 96 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.87354064 |
| 97 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.85369525 |
| 98 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.84380009 |
| 99 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.83932156 |
| 100 | SA1_27219007_Chip-Seq_Bcells_Human | 0.83135255 |
| 101 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.82879978 |
| 102 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.82355089 |
| 103 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.82233580 |
| 104 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.81821916 |
| 105 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.81706044 |
| 106 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.80385573 |
| 107 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.79791559 |
| 108 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.79513819 |
| 109 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.79392723 |
| 110 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.78682845 |
| 111 | TP53_16413492_ChIP-PET_HCT116_Human | 0.78682579 |
| 112 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.78510114 |
| 113 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.78280416 |
| 114 | * NANOG_20526341_ChIP-Seq_ESCs_Human | 0.78269038 |
| 115 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.77960949 |
| 116 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.77870028 |
| 117 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.77268549 |
| 118 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.77158331 |
| 119 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.76774407 |
| 120 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.76449684 |
| 121 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.75576226 |
| 122 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.75390942 |
| 123 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.75235506 |
| 124 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.75235506 |
| 125 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.75017413 |
| 126 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.74890125 |
| 127 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.74768678 |
| 128 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.74514792 |
| 129 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.74396348 |
| 130 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.74362334 |
| 131 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.74221725 |
| 132 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.74134364 |
| 133 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.73847531 |
| 134 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.73355416 |
| 135 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.73114594 |
| 136 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.72124242 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 6.98982494 |
| 2 | MP0001666_abnormal_nutrient_absorption | 5.45153809 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 4.47571854 |
| 4 | MP0004264_abnormal_extraembryonic_tissu | 4.37979150 |
| 5 | MP0010234_abnormal_vibrissa_follicle | 4.21694581 |
| 6 | MP0000462_abnormal_digestive_system | 4.20561578 |
| 7 | MP0005085_abnormal_gallbladder_physiolo | 3.52925199 |
| 8 | MP0003183_abnormal_peptide_metabolism | 3.46920152 |
| 9 | MP0002822_catalepsy | 3.26639558 |
| 10 | MP0009840_abnormal_foam_cell | 3.05143641 |
| 11 | MP0003283_abnormal_digestive_organ | 2.95783942 |
| 12 | MP0003252_abnormal_bile_duct | 2.90453742 |
| 13 | MP0008875_abnormal_xenobiotic_pharmacok | 2.86150301 |
| 14 | * MP0003866_abnormal_defecation | 2.81445383 |
| 15 | MP0005365_abnormal_bile_salt | 2.72585889 |
| 16 | MP0005381_digestive/alimentary_phenotyp | 2.35324384 |
| 17 | MP0001664_abnormal_digestion | 2.31826146 |
| 18 | MP0004043_abnormal_pH_regulation | 2.25113438 |
| 19 | MP0001663_abnormal_digestive_system | 2.22455840 |
| 20 | MP0000538_abnormal_urinary_bladder | 2.14568751 |
| 21 | MP0010329_abnormal_lipoprotein_level | 2.13824644 |
| 22 | MP0005409_darkened_coat_color | 2.12150915 |
| 23 | MP0010155_abnormal_intestine_physiology | 2.09522944 |
| 24 | MP0003300_gastrointestinal_ulcer | 2.05290565 |
| 25 | MP0000537_abnormal_urethra_morphology | 2.01563480 |
| 26 | MP0001873_stomach_inflammation | 1.89427030 |
| 27 | MP0000477_abnormal_intestine_morphology | 1.87207745 |
| 28 | MP0005377_hearing/vestibular/ear_phenot | 1.83800771 |
| 29 | MP0003878_abnormal_ear_physiology | 1.83800771 |
| 30 | MP0000490_abnormal_crypts_of | 1.74205423 |
| 31 | MP0010352_gastrointestinal_tract_polyps | 1.64986119 |
| 32 | MP0004019_abnormal_vitamin_homeostasis | 1.62913741 |
| 33 | MP0005670_abnormal_white_adipose | 1.60464097 |
| 34 | MP0009780_abnormal_chondrocyte_physiolo | 1.53523083 |
| 35 | MP0003868_abnormal_feces_composition | 1.49680157 |
| 36 | MP0006054_spinal_hemorrhage | 1.43640029 |
| 37 | MP0001188_hyperpigmentation | 1.42432611 |
| 38 | MP0002909_abnormal_adrenal_gland | 1.40187064 |
| 39 | MP0002138_abnormal_hepatobiliary_system | 1.37655975 |
| 40 | MP0005167_abnormal_blood-brain_barrier | 1.33847506 |
| 41 | MP0005448_abnormal_energy_balance | 1.28821721 |
| 42 | MP0004147_increased_porphyrin_level | 1.27533835 |
| 43 | MP0010386_abnormal_urinary_bladder | 1.26129353 |
| 44 | MP0005451_abnormal_body_composition | 1.23203649 |
| 45 | MP0001765_abnormal_ion_homeostasis | 1.22679235 |
| 46 | MP0009643_abnormal_urine_homeostasis | 1.21665972 |
| 47 | MP0002136_abnormal_kidney_physiology | 1.19742231 |
| 48 | MP0005084_abnormal_gallbladder_morpholo | 1.17793760 |
| 49 | MP0004782_abnormal_surfactant_physiolog | 1.16915034 |
| 50 | MP0004858_abnormal_nervous_system | 1.16789909 |
| 51 | MP0003724_increased_susceptibility_to | 1.08751799 |
| 52 | MP0000465_gastrointestinal_hemorrhage | 1.06138255 |
| 53 | MP0000678_abnormal_parathyroid_gland | 1.05646119 |
| 54 | MP0009379_abnormal_foot_pigmentation | 1.05535914 |
| 55 | MP0001849_ear_inflammation | 1.03553482 |
| 56 | MP0002254_reproductive_system_inflammat | 1.02338538 |
| 57 | MP0000613_abnormal_salivary_gland | 1.02128249 |
| 58 | MP0008872_abnormal_physiological_respon | 1.00470749 |
| 59 | MP0002796_impaired_skin_barrier | 1.00017936 |
| 60 | MP0003806_abnormal_nucleotide_metabolis | 0.98790782 |
| 61 | MP0003191_abnormal_cellular_cholesterol | 0.98538113 |
| 62 | MP0005636_abnormal_mineral_homeostasis | 0.98413539 |
| 63 | MP0003705_abnormal_hypodermis_morpholog | 0.94917555 |
| 64 | MP0000230_abnormal_systemic_arterial | 0.94576292 |
| 65 | MP0002971_abnormal_brown_adipose | 0.92862453 |
| 66 | MP0008004_abnormal_stomach_pH | 0.92546799 |
| 67 | MP0005310_abnormal_salivary_gland | 0.90724833 |
| 68 | MP0002118_abnormal_lipid_homeostasis | 0.90200033 |
| 69 | MP0002166_altered_tumor_susceptibility | 0.88642860 |
| 70 | MP0001845_abnormal_inflammatory_respons | 0.88158999 |
| 71 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.87688309 |
| 72 | MP0000516_abnormal_urinary_system | 0.87120103 |
| 73 | MP0005367_renal/urinary_system_phenotyp | 0.87120103 |
| 74 | MP0002693_abnormal_pancreas_physiology | 0.86352311 |
| 75 | MP0000609_abnormal_liver_physiology | 0.83681226 |
| 76 | MP0000470_abnormal_stomach_morphology | 0.81238885 |
| 77 | MP0005535_abnormal_body_temperature | 0.79461658 |
| 78 | MP0002098_abnormal_vibrissa_morphology | 0.79450865 |
| 79 | MP0009115_abnormal_fat_cell | 0.78209852 |
| 80 | MP0005332_abnormal_amino_acid | 0.78011599 |
| 81 | MP0000467_abnormal_esophagus_morphology | 0.77906496 |
| 82 | MP0009697_abnormal_copulation | 0.77498261 |
| 83 | MP0002089_abnormal_postnatal_growth/wei | 0.77348082 |
| 84 | MP0005187_abnormal_penis_morphology | 0.76505717 |
| 85 | MP0010678_abnormal_skin_adnexa | 0.74709265 |
| 86 | MP0004270_analgesia | 0.74019123 |
| 87 | MP0009384_cardiac_valve_regurgitation | 0.72331341 |
| 88 | MP0004947_skin_inflammation | 0.71705202 |
| 89 | MP0001764_abnormal_homeostasis | 0.70645729 |
| 90 | MP0008469_abnormal_protein_level | 0.70127270 |
| 91 | MP0003303_peritoneal_inflammation | 0.68728010 |
| 92 | MP0001835_abnormal_antigen_presentation | 0.68278522 |
| 93 | MP0003119_abnormal_digestive_system | 0.67763417 |
| 94 | MP0006082_CNS_inflammation | 0.66743303 |
| 95 | MP0002277_abnormal_respiratory_mucosa | 0.66268585 |
| 96 | MP0003453_abnormal_keratinocyte_physiol | 0.66072294 |
| 97 | MP0005666_abnormal_adipose_tissue | 0.66022621 |
| 98 | MP0001944_abnormal_pancreas_morphology | 0.65974089 |
| 99 | MP0002078_abnormal_glucose_homeostasis | 0.65083415 |
| 100 | MP0002396_abnormal_hematopoietic_system | 0.63775862 |
| 101 | MP0002006_tumorigenesis | 0.63561065 |
| 102 | MP0002163_abnormal_gland_morphology | 0.63340804 |
| 103 | MP0003953_abnormal_hormone_level | 0.62305931 |
| 104 | MP0005379_endocrine/exocrine_gland_phen | 0.62177235 |
| 105 | MP0005248_abnormal_Harderian_gland | 0.61628249 |
| 106 | MP0005166_decreased_susceptibility_to | 0.61559113 |
| 107 | MP0005220_abnormal_exocrine_pancreas | 0.59550144 |
| 108 | MP0001756_abnormal_urination | 0.59237385 |
| 109 | MP0005058_abnormal_lysosome_morphology | 0.59084439 |
| 110 | MP0002896_abnormal_bone_mineralization | 0.58297690 |
| 111 | MP0002876_abnormal_thyroid_physiology | 0.57918931 |
| 112 | MP0000249_abnormal_blood_vessel | 0.56866688 |
| 113 | * MP0005025_abnormal_response_to | 0.56803731 |
| 114 | MP0003879_abnormal_hair_cell | 0.56250948 |
| 115 | MP0003436_decreased_susceptibility_to | 0.55891902 |
| 116 | MP0000566_synostosis | 0.55284480 |
| 117 | MP0000569_abnormal_digit_pigmentation | 0.54974775 |
| 118 | MP0003315_abnormal_perineum_morphology | 0.54132189 |
| 119 | MP0005319_abnormal_enzyme/_coenzyme | 0.53079756 |
| 120 | MP0001790_abnormal_immune_system | 0.52710476 |
| 121 | MP0005387_immune_system_phenotype | 0.52710476 |
| 122 | MP0002009_preneoplasia | 0.52475552 |
| 123 | MP0009764_decreased_sensitivity_to | 0.52179108 |
| 124 | MP0003693_abnormal_embryo_hatching | 0.52070626 |
| 125 | MP0009642_abnormal_blood_homeostasis | 0.51045073 |
| 126 | MP0001216_abnormal_epidermal_layer | 0.50443676 |
| 127 | MP0005266_abnormal_metabolism | 0.48776524 |
| 128 | MP0000604_amyloidosis | 0.48672421 |
| 129 | MP0001881_abnormal_mammary_gland | 0.48628871 |
| 130 | MP0003718_maternal_effect | 0.48162103 |
| 131 | MP0000427_abnormal_hair_cycle | 0.48152206 |
| 132 | MP0004484_altered_response_of | 0.48069831 |
| 133 | MP0001485_abnormal_pinna_reflex | 0.47487359 |
| 134 | MP0008961_abnormal_basal_metabolism | 0.46042089 |
| 135 | MP0001501_abnormal_sleep_pattern | 0.45971226 |
| 136 | MP0009333_abnormal_splenocyte_physiolog | 0.45744322 |
| 137 | MP0005501_abnormal_skin_physiology | 0.44975021 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Conjugated hyperbilirubinemia (HP:0002908) | 6.50277565 |
| 2 | Right ventricular cardiomyopathy (HP:0011663) | 5.41352114 |
| 3 | Hypobetalipoproteinemia (HP:0003563) | 5.23419338 |
| 4 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 5.18339541 |
| 5 | Malnutrition (HP:0004395) | 5.10804676 |
| 6 | Acanthocytosis (HP:0001927) | 5.06027002 |
| 7 | * Ileus (HP:0002595) | 4.44478581 |
| 8 | Abdominal distention (HP:0003270) | 4.26542235 |
| 9 | Fat malabsorption (HP:0002630) | 4.24870177 |
| 10 | Chronic diarrhea (HP:0002028) | 3.93180897 |
| 11 | Systemic lupus erythematosus (HP:0002725) | 3.91782420 |
| 12 | Confusion (HP:0001289) | 3.91148553 |
| 13 | Symptomatic seizures (HP:0011145) | 3.88487027 |
| 14 | Villous atrophy (HP:0011473) | 3.67317969 |
| 15 | Abnormality of small intestinal villus morphology (HP:0011472) | 3.67317969 |
| 16 | Abnormality of the 1st metacarpal (HP:0010009) | 3.67281881 |
| 17 | Congenital sensorineural hearing impairment (HP:0008527) | 3.66323458 |
| 18 | Alkalosis (HP:0001948) | 3.61548041 |
| 19 | Intrahepatic cholestasis (HP:0001406) | 3.55243284 |
| 20 | Hydroxyprolinuria (HP:0003080) | 3.50311390 |
| 21 | Abnormality of proline metabolism (HP:0010907) | 3.50311390 |
| 22 | Hyperactive renin-angiotensin system (HP:0000841) | 3.48182291 |
| 23 | Abnormal biliary tract morphology (HP:0012440) | 3.37455800 |
| 24 | Widely patent fontanelles and sutures (HP:0004492) | 3.35492161 |
| 25 | Flat acetabular roof (HP:0003180) | 3.35262084 |
| 26 | Cupped ribs (HP:0000887) | 3.33746688 |
| 27 | Ventricular fibrillation (HP:0001663) | 3.31907072 |
| 28 | Autoimmune hemolytic anemia (HP:0001890) | 3.24513725 |
| 29 | Autoimmune thrombocytopenia (HP:0001973) | 3.22167612 |
| 30 | * Abnormality of the vitamin B12 metabolism (HP:0004341) | 3.21175359 |
| 31 | Nausea (HP:0002018) | 3.20222275 |
| 32 | Facial shape deformation (HP:0011334) | 3.14947819 |
| 33 | Potter facies (HP:0002009) | 3.14947819 |
| 34 | Rectal prolapse (HP:0002035) | 3.14470624 |
| 35 | Proximal tubulopathy (HP:0000114) | 3.14161262 |
| 36 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.11900995 |
| 37 | Abnormality of urine glucose concentration (HP:0011016) | 3.10693853 |
| 38 | Glycosuria (HP:0003076) | 3.10693853 |
| 39 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.07295578 |
| 40 | Abnormality of chloride homeostasis (HP:0011422) | 3.07189275 |
| 41 | Abnormality of glycine metabolism (HP:0010895) | 3.06877038 |
| 42 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.06877038 |
| 43 | Progressive sensorineural hearing impairment (HP:0000408) | 3.03886944 |
| 44 | Pigmentary retinal degeneration (HP:0001146) | 3.03826830 |
| 45 | Abnormality of the gastric mucosa (HP:0004295) | 3.02334422 |
| 46 | Hypoglycemic seizures (HP:0002173) | 3.01246583 |
| 47 | Dehydration (HP:0001944) | 3.00954938 |
| 48 | Hypoglycemic coma (HP:0001325) | 2.98273134 |
| 49 | Late onset (HP:0003584) | 2.97064230 |
| 50 | * Abnormality of vitamin B metabolism (HP:0004340) | 2.96798577 |
| 51 | Hypolipoproteinemia (HP:0010981) | 2.96063420 |
| 52 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.90712211 |
| 53 | Eczematoid dermatitis (HP:0000976) | 2.87845850 |
| 54 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.78409158 |
| 55 | Syncope (HP:0001279) | 2.78126211 |
| 56 | Hemorrhage of the eye (HP:0011885) | 2.77460703 |
| 57 | Hyperparathyroidism (HP:0000843) | 2.75477902 |
| 58 | Progressive hearing impairment (HP:0001730) | 2.75460591 |
| 59 | Steatorrhea (HP:0002570) | 2.75409940 |
| 60 | Metabolic alkalosis (HP:0200114) | 2.68414448 |
| 61 | Increased purine levels (HP:0004368) | 2.67426657 |
| 62 | Hyperuricemia (HP:0002149) | 2.67426657 |
| 63 | Poikilocytosis (HP:0004447) | 2.63995986 |
| 64 | Abnormal tarsal ossification (HP:0008369) | 2.57336580 |
| 65 | Hyperaldosteronism (HP:0000859) | 2.55976101 |
| 66 | Palpitations (HP:0001962) | 2.55538298 |
| 67 | Megaloblastic anemia (HP:0001889) | 2.55144128 |
| 68 | Hypercholesterolemia (HP:0003124) | 2.54915773 |
| 69 | Hyperphosphaturia (HP:0003109) | 2.54657798 |
| 70 | Pustule (HP:0200039) | 2.52129150 |
| 71 | Posterior subcapsular cataract (HP:0007787) | 2.47883125 |
| 72 | * Abnormality of vitamin metabolism (HP:0100508) | 2.46533254 |
| 73 | Focal segmental glomerulosclerosis (HP:0000097) | 2.44583920 |
| 74 | Ketoacidosis (HP:0001993) | 2.44553680 |
| 75 | Hypotension (HP:0002615) | 2.43073143 |
| 76 | Short phalanx of the thumb (HP:0009660) | 2.40639161 |
| 77 | Enlarged epiphyses (HP:0010580) | 2.38578102 |
| 78 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.38104404 |
| 79 | Wide cranial sutures (HP:0010537) | 2.36130708 |
| 80 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.34245797 |
| 81 | Hyperglycemia (HP:0003074) | 2.31645294 |
| 82 | Male infertility (HP:0003251) | 2.31190821 |
| 83 | Abnormality of nucleobase metabolism (HP:0010932) | 2.29027141 |
| 84 | Abnormality of purine metabolism (HP:0004352) | 2.27895519 |
| 85 | Decreased circulating renin level (HP:0003351) | 2.26432465 |
| 86 | Cheilitis (HP:0100825) | 2.23267658 |
| 87 | Pili torti (HP:0003777) | 2.22838356 |
| 88 | Woolly hair (HP:0002224) | 2.22448644 |
| 89 | Delayed epiphyseal ossification (HP:0002663) | 2.22438883 |
| 90 | Abnormality of renin-angiotensin system (HP:0000847) | 2.20746800 |
| 91 | Pancreatitis (HP:0001733) | 2.19594978 |
| 92 | Hypokalemia (HP:0002900) | 2.17987249 |
| 93 | Xanthomatosis (HP:0000991) | 2.16352716 |
| 94 | Hyperphosphatemia (HP:0002905) | 2.16267714 |
| 95 | Glomerulonephritis (HP:0000099) | 2.14589995 |
| 96 | Nephrolithiasis (HP:0000787) | 2.14114533 |
| 97 | Biliary tract neoplasm (HP:0100574) | 2.11906869 |
| 98 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.11148081 |
| 99 | Protuberant abdomen (HP:0001538) | 2.10780762 |
| 100 | Abnormal urine phosphate concentration (HP:0012599) | 2.10337323 |
| 101 | Micronodular cirrhosis (HP:0001413) | 2.10252029 |
| 102 | Prolonged QT interval (HP:0001657) | 2.09889850 |
| 103 | Gingivitis (HP:0000230) | 2.09806813 |
| 104 | Milia (HP:0001056) | 2.09042333 |
| 105 | Abnormal pancreas size (HP:0012094) | 2.08952157 |
| 106 | Bundle branch block (HP:0011710) | 2.08392043 |
| 107 | Abnormality of the costochondral junction (HP:0000919) | 2.08259020 |
| 108 | Thin bony cortex (HP:0002753) | 2.07930171 |
| 109 | Gout (HP:0001997) | 2.07782024 |
| 110 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.06138214 |
| 111 | Abnormality of carpal bone ossification (HP:0006257) | 2.04236414 |
| 112 | Abnormality of complement system (HP:0005339) | 2.04071689 |
| 113 | Abnormal foot bone ossification (HP:0010675) | 2.04069477 |
| 114 | Abnormality of potassium homeostasis (HP:0011042) | 2.03827581 |
| 115 | Short 1st metacarpal (HP:0010034) | 2.02797713 |
| 116 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 2.02797713 |
| 117 | Fragile skin (HP:0001030) | 2.02527274 |
| 118 | Ankyloglossia (HP:0010296) | 2.01927419 |
| 119 | Complement deficiency (HP:0004431) | 2.01101990 |
| 120 | Dicarboxylic aciduria (HP:0003215) | 1.99372164 |
| 121 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.99372164 |
| 122 | Abnormal glucose tolerance (HP:0001952) | 1.99227454 |
| 123 | Subcapsular cataract (HP:0000523) | 1.98658726 |
| 124 | Epidermoid cyst (HP:0200040) | 1.98217846 |
| 125 | Hyperglycinuria (HP:0003108) | 1.97747863 |
| 126 | Renal tubular acidosis (HP:0001947) | 1.97240745 |
| 127 | Mesangial abnormality (HP:0001966) | 1.95836675 |
| 128 | Hyperbilirubinemia (HP:0002904) | 1.95667949 |
| 129 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.95437011 |
| 130 | Abnormality of magnesium homeostasis (HP:0004921) | 1.94735092 |
| 131 | Cerebral palsy (HP:0100021) | 1.93508064 |
| 132 | Exocrine pancreatic insufficiency (HP:0001738) | 1.93227428 |
| 133 | Curly hair (HP:0002212) | 1.91505239 |
| 134 | Metabolic acidosis (HP:0001942) | 1.88815274 |
| 135 | Increased mean platelet volume (HP:0011877) | 1.87746220 |
| 136 | Nephritis (HP:0000123) | 1.87188195 |
| 137 | Plantar hyperkeratosis (HP:0007556) | 1.85686304 |
| 138 | Hypophosphatemia (HP:0002148) | 1.83882254 |
| 139 | Hyperammonemia (HP:0001987) | 1.83808865 |
| 140 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 1.83566398 |
| 141 | Hyponatremia (HP:0002902) | 1.83423940 |
| 142 | Glomerulosclerosis (HP:0000096) | 1.82435535 |
| 143 | Microretrognathia (HP:0000308) | 1.81932649 |
| 144 | Insulin resistance (HP:0000855) | 1.81497857 |
| 145 | Severe short stature (HP:0003510) | 1.80730507 |
| 146 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.75901831 |
| 147 | Petechiae (HP:0000967) | 1.74511322 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 6.75833838 |
| 2 | LMTK2 | 6.56085681 |
| 3 | MST1R | 4.34489218 |
| 4 | MST4 | 3.95987031 |
| 5 | PRKG2 | 3.53597567 |
| 6 | NME1 | 2.98502573 |
| 7 | TAOK3 | 2.78985396 |
| 8 | MAP2K2 | 2.49854403 |
| 9 | RIPK1 | 2.49099573 |
| 10 | MAP3K2 | 2.36876932 |
| 11 | GRK6 | 2.10026898 |
| 12 | NUAK1 | 2.09008493 |
| 13 | EPHA2 | 2.03992480 |
| 14 | FGFR4 | 1.90920623 |
| 15 | INSRR | 1.90504724 |
| 16 | PTK6 | 1.88949930 |
| 17 | AKT3 | 1.76549982 |
| 18 | MAP3K10 | 1.73207095 |
| 19 | ERN1 | 1.70500467 |
| 20 | EPHA3 | 1.67086212 |
| 21 | STK24 | 1.55597744 |
| 22 | MET | 1.55275526 |
| 23 | TESK1 | 1.53150270 |
| 24 | EPHB2 | 1.52694921 |
| 25 | PIK3CA | 1.44299119 |
| 26 | TYK2 | 1.39300510 |
| 27 | DYRK1B | 1.33330410 |
| 28 | MAP2K6 | 1.33166663 |
| 29 | TESK2 | 1.33145085 |
| 30 | PDK2 | 1.28951470 |
| 31 | PTK2 | 1.25710302 |
| 32 | TNIK | 1.22941811 |
| 33 | LATS1 | 1.22344758 |
| 34 | KSR2 | 1.16331222 |
| 35 | MYLK | 1.13161464 |
| 36 | ERBB2 | 1.10584045 |
| 37 | NLK | 1.09623129 |
| 38 | MAP3K1 | 1.08046143 |
| 39 | PRKCI | 1.03694982 |
| 40 | FGFR3 | 1.03435749 |
| 41 | PRPF4B | 0.98135891 |
| 42 | TTK | 0.96838255 |
| 43 | MAP4K1 | 0.90567801 |
| 44 | PASK | 0.88468507 |
| 45 | ERBB4 | 0.88254218 |
| 46 | SIK3 | 0.86209163 |
| 47 | MAP2K1 | 0.82593372 |
| 48 | FER | 0.81018944 |
| 49 | BCR | 0.80560626 |
| 50 | MAP3K9 | 0.78495286 |
| 51 | PRKAA2 | 0.76832685 |
| 52 | IRAK1 | 0.72765304 |
| 53 | DDR2 | 0.71382064 |
| 54 | PRKAA1 | 0.70302785 |
| 55 | KSR1 | 0.68050880 |
| 56 | YES1 | 0.66467537 |
| 57 | MAPK15 | 0.66133424 |
| 58 | CASK | 0.65984877 |
| 59 | SCYL2 | 0.65163251 |
| 60 | CAMK2D | 0.61696592 |
| 61 | PAK3 | 0.61207339 |
| 62 | DMPK | 0.61152553 |
| 63 | WNK4 | 0.60799746 |
| 64 | MAP3K8 | 0.60576506 |
| 65 | PDK1 | 0.60406358 |
| 66 | HIPK2 | 0.58484367 |
| 67 | MATK | 0.58297842 |
| 68 | IRAK3 | 0.54908445 |
| 69 | MAP3K3 | 0.53131619 |
| 70 | MAPK11 | 0.52951776 |
| 71 | EPHA4 | 0.51726876 |
| 72 | STK39 | 0.51406393 |
| 73 | PAK4 | 0.49651777 |
| 74 | PIM1 | 0.47122661 |
| 75 | BMPR1B | 0.46927781 |
| 76 | CSK | 0.46518899 |
| 77 | RIPK4 | 0.45686896 |
| 78 | CDC42BPA | 0.45275504 |
| 79 | BMPR2 | 0.44885304 |
| 80 | CAMK2B | 0.44106802 |
| 81 | JAK2 | 0.43998835 |
| 82 | BRAF | 0.43883432 |
| 83 | GRK1 | 0.43298388 |
| 84 | CSNK1A1 | 0.43067301 |
| 85 | MAP3K7 | 0.42545517 |
| 86 | PBK | 0.42332036 |
| 87 | PRKCZ | 0.42147844 |
| 88 | ZAP70 | 0.41394393 |
| 89 | TAOK1 | 0.39970124 |
| 90 | BLK | 0.38631980 |
| 91 | JAK1 | 0.37825900 |
| 92 | ABL2 | 0.37511218 |
| 93 | TBK1 | 0.37450467 |
| 94 | NEK6 | 0.36247560 |
| 95 | EEF2K | 0.35497432 |
| 96 | EPHB1 | 0.35418588 |
| 97 | STK10 | 0.35189029 |
| 98 | CAMK2G | 0.34857546 |
| 99 | MAP3K11 | 0.34036956 |
| 100 | CDK6 | 0.33851816 |
| 101 | CDK19 | 0.33081985 |
| 102 | AURKB | 0.33076519 |
| 103 | SIK1 | 0.31714751 |
| 104 | LIMK1 | 0.31576635 |
| 105 | * PRKCA | 0.30380441 |
| 106 | PRKACG | 0.30145004 |
| 107 | ACVR1B | 0.29141247 |
| 108 | IKBKE | 0.29011515 |
| 109 | MAP3K14 | 0.28882279 |
| 110 | ROCK1 | 0.28806566 |
| 111 | CSF1R | 0.28016562 |
| 112 | PDPK1 | 0.27837431 |
| 113 | PDGFRA | 0.27544994 |
| 114 | PIK3CG | 0.27503587 |
| 115 | PRKCD | 0.27252641 |
| 116 | ICK | 0.27173789 |
| 117 | MAP3K12 | 0.26838169 |
| 118 | MELK | 0.25376959 |
| 119 | RET | 0.24395848 |
| 120 | MAP3K5 | 0.23854322 |
| 121 | CSNK1E | 0.23843508 |
| 122 | BTK | 0.21897137 |
| 123 | FGR | 0.21876952 |
| 124 | IGF1R | 0.21327881 |
| 125 | SRC | 0.20221944 |
| 126 | LYN | 0.19983501 |
| 127 | IRAK4 | 0.19851449 |
| 128 | PINK1 | 0.19508233 |
| 129 | OXSR1 | 0.18891164 |
| 130 | STK11 | 0.18545217 |
| 131 | FYN | 0.18261878 |
| 132 | PAK1 | 0.17838161 |
| 133 | STK3 | 0.16705797 |
| 134 | GSK3A | 0.15602740 |
| 135 | BMX | 0.15284449 |
| 136 | AKT2 | 0.15202221 |
| 137 | MAPKAPK2 | 0.14945316 |
| 138 | CDK5 | 0.13847307 |
| 139 | ARAF | 0.13031032 |
| 140 | CSNK1G1 | 0.12893421 |
| 141 | MAPKAPK5 | 0.12538502 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fat digestion and absorption_Homo sapiens_hsa04975 | 4.92753440 |
| 2 | Sulfur metabolism_Homo sapiens_hsa00920 | 4.57561334 |
| 3 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 4.51290292 |
| 4 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 4.11312251 |
| 5 | Mineral absorption_Homo sapiens_hsa04978 | 3.71735876 |
| 6 | Renin-angiotensin system_Homo sapiens_hsa04614 | 3.12919529 |
| 7 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.76832295 |
| 8 | Galactose metabolism_Homo sapiens_hsa00052 | 2.65131953 |
| 9 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 2.46956586 |
| 10 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.36956506 |
| 11 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.33007408 |
| 12 | Bile secretion_Homo sapiens_hsa04976 | 2.19206619 |
| 13 | Histidine metabolism_Homo sapiens_hsa00340 | 2.16673773 |
| 14 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.09799526 |
| 15 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.93705714 |
| 16 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.93239627 |
| 17 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.92870982 |
| 18 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.77500452 |
| 19 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.74329617 |
| 20 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.72520632 |
| 21 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.67617560 |
| 22 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.60999640 |
| 23 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.48385296 |
| 24 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.48133593 |
| 25 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.46111390 |
| 26 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.33129308 |
| 27 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.14601481 |
| 28 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.11965243 |
| 29 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.10308370 |
| 30 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.06432135 |
| 31 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.05291127 |
| 32 | ABC transporters_Homo sapiens_hsa02010 | 1.05023280 |
| 33 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.01096991 |
| 34 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.99693440 |
| 35 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.98559831 |
| 36 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.95802905 |
| 37 | Asthma_Homo sapiens_hsa05310 | 0.93016519 |
| 38 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.90253615 |
| 39 | Insulin secretion_Homo sapiens_hsa04911 | 0.89734868 |
| 40 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.87281654 |
| 41 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.83733680 |
| 42 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.81842534 |
| 43 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.79546644 |
| 44 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.78808772 |
| 45 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.78662546 |
| 46 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.78616813 |
| 47 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.77883760 |
| 48 | Tight junction_Homo sapiens_hsa04530 | 0.74614389 |
| 49 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.71622983 |
| 50 | Allograft rejection_Homo sapiens_hsa05330 | 0.70555759 |
| 51 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.67571949 |
| 52 | Cocaine addiction_Homo sapiens_hsa05030 | 0.67041342 |
| 53 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.65048468 |
| 54 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.63195872 |
| 55 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.62879469 |
| 56 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.62773643 |
| 57 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.62770204 |
| 58 | Other glycan degradation_Homo sapiens_hsa00511 | 0.62449154 |
| 59 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.60532745 |
| 60 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.59652775 |
| 61 | Retinol metabolism_Homo sapiens_hsa00830 | 0.58162102 |
| 62 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.55541239 |
| 63 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.54838805 |
| 64 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.54537164 |
| 65 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.52061239 |
| 66 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.48014627 |
| 67 | Carbon metabolism_Homo sapiens_hsa01200 | 0.47172119 |
| 68 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.46880305 |
| 69 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.46812643 |
| 70 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.46621266 |
| 71 | Thyroid cancer_Homo sapiens_hsa05216 | 0.46390242 |
| 72 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.45685664 |
| 73 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.43460676 |
| 74 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.41933893 |
| 75 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.41781419 |
| 76 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.41340628 |
| 77 | Bladder cancer_Homo sapiens_hsa05219 | 0.40950480 |
| 78 | Salivary secretion_Homo sapiens_hsa04970 | 0.39866520 |
| 79 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.36732025 |
| 80 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.34650385 |
| 81 | Leishmaniasis_Homo sapiens_hsa05140 | 0.32959601 |
| 82 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.32751721 |
| 83 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.32077603 |
| 84 | Metabolic pathways_Homo sapiens_hsa01100 | 0.31759976 |
| 85 | Adherens junction_Homo sapiens_hsa04520 | 0.31414874 |
| 86 | Lysine degradation_Homo sapiens_hsa00310 | 0.31372603 |
| 87 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.31163138 |
| 88 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.30966802 |
| 89 | Salmonella infection_Homo sapiens_hsa05132 | 0.30965505 |
| 90 | Sulfur relay system_Homo sapiens_hsa04122 | 0.29570108 |
| 91 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.29567367 |
| 92 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.27465359 |
| 93 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.26407492 |
| 94 | Hepatitis C_Homo sapiens_hsa05160 | 0.26058147 |
| 95 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.25184204 |
| 96 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.24985390 |
| 97 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.24842308 |
| 98 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.23405657 |
| 99 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.22804068 |
| 100 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.22800681 |
| 101 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.22102790 |
| 102 | Alzheimers disease_Homo sapiens_hsa05010 | 0.21594327 |
| 103 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.17237844 |
| 104 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.17234251 |
| 105 | Peroxisome_Homo sapiens_hsa04146 | 0.17162950 |
| 106 | Renin secretion_Homo sapiens_hsa04924 | 0.17117673 |
| 107 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.16947213 |
| 108 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.16905507 |
| 109 | Pertussis_Homo sapiens_hsa05133 | 0.16756986 |
| 110 | Insulin resistance_Homo sapiens_hsa04931 | 0.15379502 |
| 111 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.15204008 |
| 112 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.14265470 |
| 113 | Parkinsons disease_Homo sapiens_hsa05012 | 0.13457672 |
| 114 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.12850714 |
| 115 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.12694392 |
| 116 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.09865026 |
| 117 | Viral myocarditis_Homo sapiens_hsa05416 | 0.09773361 |
| 118 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.08827297 |
| 119 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.08642141 |
| 120 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.07885664 |
| 121 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.07545898 |
| 122 | Gap junction_Homo sapiens_hsa04540 | 0.06921700 |
| 123 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.06525939 |
| 124 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.05914210 |
| 125 | Influenza A_Homo sapiens_hsa05164 | 0.03256048 |
| 126 | Tuberculosis_Homo sapiens_hsa05152 | 0.02975016 |

